Human DCTN1: Genomic structure and evaluation as a candidate for Alstrom syndrome

Genomics

Volumn 53, Issue 3, 1998, Pages 359-364

  Collin, Gayle B ^a   Nishina, Patsy M ^a   Marshall, Jan D ^a   Naggert, Jürgen K ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENE MUTATION; GENE SEGREGATION; GENE STRUCTURE; GENOME; HUMAN; HYPERPHAGIA; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; RETINA DEGENERATION; SYNDROME;

IMPLETA;

EID: 0032213761     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1998.5542     Document Type: Article

References (18)

1. Allan V. Motor proteins: A dynamic duo. Curr. Biol. 6:1996;630-633.
2. Alström C. H., Hallgren B., Nilsson L. B., Asander H. Retinal degeneration combined with obesity, diabetes mellitus and neurogenous deafness. A specific syndrome (not hitherto described) distinct from Laurence-Moon-Biedl syndrome. A clinical endocrinological and genetic examination based on a large pedigree. Acta Psychiatr. Neurol. Scand. 1959;1-35.
3. Bashir R., Keers S., Strachan T., Passos Bueno R., Zatz M., Weissenbach J., Le Paslier D., Meisler M. and Bushby. Genetic and physical mapping at the limb-girdle muscular dystrophy locus (LGMD2B) on chromosome 2p. Genomics. 33:1996;46-52.
4. Bejaoui K., Hirabayashi K., Hentati F., Haines J. L., Ben Hamida C., Belal S., Miller R. G., McKenna Yasek D., Weissenbach J., Rowland L. P. Linkage of Miyoshi myopathy (distal autosomal recessive muscular dystrophy) locus to chromosome 2p12-14. Neurology. 45:1995;768-772.
5. Collin G. B., Marshall J. D., Cardon L. R., Nishina P. M. Homozygosity mapping at Alström syndrome to chromosome 2p. Hum. Mol. Genet. 6:1997;213-219.
6. Fan S. S., Ready D. F. Glued participates in distinct microtubule-based activities inDrosophila. Development. 124:1997;1497-1507.
7. Gill S. R., Schroer T. A., Szilak I., Steuer E. R., Sheetz M. P., Cleveland D. W. Dynactin, a conserved, ubiquitously expressed component of an activator of vesicle motility mediated by cytoplasmic dynein. J. Cell Biol. 115:1991;1639-1650.
8. Gluedto human chromosome 2p13 by fluorescencein situ. Genomics. 31:1996;398-399.
9. Glued(dynactin 1) cDNA sequence and evaluation as a candidate for the neuromuscular disease mutation mnd2. Biochem. Biophys. Res. Commun. 231:1997;344-347.
10. Jones J. M., Albin R. L., Feldman E. L., Simin K., Schuster T. G., Dunnick W. A., Collins J. T., Chrisp C. E., Taylor B. A., Meisler M. H. mnd2: Genomics. 16:1993;669-677.
11. Marshall J. D., Ludman M. D., Shea S. E., Salisbury S. R., Willi S. M., LaRoche R. G., Nishina P. M. Genealogy, natural history, and phenotype of Alström syndrome in a large Acadian kindred and three additional families. Am. J. Med. Genet. 73:1997;150-161.
12. Gluedcomponent of the dynactin complex in developing and adult rat brain. J. Comp. Neurol. 357:1995;15-24.
13. Mount S. M. A catalogue of splice junction sequences. Nucleic Acids Res. 10:1982;459-472.
14. Reddy S., Jin P., Trimarchi J., Caruccio P., Phillis R., Murphey R. K. Mutant molecular motors disrupt neural circuits. Drosophila. J. Neurobiol. 1997;711-723.
15. Reese M. G., Eeckman F. H., Kulp D., Haussler D. Improved splice site detection in Genie. Proceedings of the First Annual International Conference on Computational Molecular Biology (RECOMB), 1997;ACM Press, New York.
16. Smale S. T., Baltimore D. The "initiator" as a transcription control element. Cell. 57:1989;103-113.
17. Tokito M. K., Howland D. S., Lee V. M., Holzbaur E. L. Functionally distinct isoforms of dynactin are expressed in human neurons. Mol. Biol. Cell. 7:1996;1167-1180.
18. Tremblay F., LaRoche R. G., Shea S. E., Ludman M. D. Longitudinal study of the early electroretinographic changes in Alström's syndrome. Am. J. Opthalmol. 115:1993;657-665.